Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Apovac F.M.B.A.
FMA
Active
CVR 40504044
Smørmosevej 16C, 2880
Bagsværd
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2019 · 7 years old
5 employees
www.apovac.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Apovac F.M.B.A.
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
19M
14M
9M
5M
0M
2022: 11M
11M
2022
2023: 2M (-82% vs 2022)
2M
-82%
2023
2024: 15M (+650% vs 2023)
15M
+650%
2024
2024: 3M (-80% vs 2024)
3M
-80%
2024
2025: 3M (0% vs 2024)
3M
0%
2025
EBITDA
DKK millions
16M
11M
6M
0M
-5M
2022: 9M
9M
2022
2023: -1M (-111% vs 2022)
-1M
-111%
2023
2024: 12M (+1300% vs 2023)
12M
+1300%
2024
2024: 1M (-92% vs 2024)
1M
-92%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2024
2023
2022
Gross profit
3.387
3.043
14.968
2.019
10.871
Staff expenses
-2.675
-2.280
-2.664
-3.410
-1.973
EBITDA
712
763
12.304
-1.391
8.898
Depreciation & amort.
-1.573
-1.049
-935
-610
-335
EBIT
-861
-286
11.370
-2.001
8.563
Net financials
49
125
-163
-61
-136
Profit before tax
-812
-161
11.207
-2.061
8.427
Tax
-118
-16
2.471
-376
656
Net profit
-694
-146
8.736
-1.685
7.771
Balance sheet
DKK thousands
Item
2025
2024
2024
2023
2022
Total assets
12.843
13.874
21.470
7.094
9.065
Equity
11.493
12.157
12.251
3.425
5.028
Long-term debt
0
0
200
3.130
0
Short-term debt
776
934
8.198
539
3.989
Total debt
776
934
8.398
3.669
3.989
Financial ratios
5-year trend
EBITDA margin (of gross profit)
21,0 %
This company
2022
2025
Equity ratio
89,5 %
This company
38,2 %
Market median
This company
Market median
134% above market
2022
2025
Return on equity
-6,0 %
This company
18,4 %
Market median
This company
Market median
133% below market
2022
2025
Net profit margin (of gross profit)
-20,5 %
This company
2022
2025
Asset turnover (of gross profit)
0,26×
This company
2022
2025
Debt / equity
0,12×
This company
0,62×
Market median
This company
Market median
81% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-04-01 – 2024-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
More on Apovac F.M.B.A.
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
